HOME  >  Pipelines

Platform Technology

Platform Technology

Indication : Metastatic or recurrent cancer

Development stage : Preparing phase I clinical trial

Systemically administrable GM oncolytic virus platform
  • - Systemically administrable → able to treat metastatic cancer
  • - Tumor-targeted → improved therapeutic efficacy and safety profile
  • - Attenuation of nonspecific hepatic accumulation
  • - Elongation in blood circulation time for improved efficacy
TOP